Systemic Lupus Erythematosus

Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients
Mariko Ogawa-Momohara, Yoshinao Muro, Masashi Akiyama

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216375; DOI: 10.1136/annrheumdis-2019-216375
Difference between SLE classification and diagnosis and importance of attribution. Response to: ‘Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?’ by Chi et al
Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216338; DOI: 10.1136/annrheumdis-2019-216338
The heart of anti-Ku related disease: extensive review and meta-analysis. Response to: ‘Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis’ by Campochiaro et al
Lionel Spielmann, François Séverac, Alain Meyer

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-216095; DOI: 10.1136/annrheumdis-2019-216095
Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS’ by Assan et al
Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-216250; DOI: 10.1136/annrheumdis-2019-216250
Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?
Huihui Chi, Jialin Teng, Zhihong Wang, Chengde Yang, Yutong Su

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-216253; DOI: 10.1136/annrheumdis-2019-216253
Successful treatment of arthritis and rash with tofacitinib in systemic lupus erythematosus: the experience from a single centre
Hanxiao You, Guizhi Zhang, Qian Wang, Shangzhu Zhang, Jiuliang Zhao, Xinping Tian, Hongbin Li, Mengtao Li, Xiaofeng Zeng

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1441-1443; DOI: 10.1136/annrheumdis-2019-215455
Variation in antinuclear antibody detection: need for clear expectations and additional studies
Michael Mahler, Carolina Auza

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e118; DOI: 10.1136/annrheumdis-2018-213888
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G Tektonidou, Laura Andreoli, Marteen Limper, Zahir Amoura, Ricard Cervera, Nathalie Costedoat-Chalumeau, Maria Jose Cuadrado, Thomas Dörner, Raquel Ferrer-Oliveras, Karen Hambly, Munther A Khamashta, Judith King, Francesca Marchiori, Pier Luigi Meroni, Marta Mosca, Vittorio Pengo, Luigi Raio, Guillermo Ruiz-Irastorza, Yehuda Shoenfeld, Ljudmila Stojanovich, Elisabet Svenungsson, Denis Wahl, Angela Tincani, Michael M Ward

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1296-1304; DOI: 10.1136/annrheumdis-2019-215213
New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS
Florence Assan, Raphaele Seror, Xavier Mariette, Gaetane Nocturne

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-216222; DOI: 10.1136/annrheumdis-2019-216222
Response to ‘Steroid sparing effect: an essential element in assessing therapeutic efficacy in SLE: response to ‘Time to change the primary outcome of lupus trials’ by Houssiau’ by Oon et al
Frederic A Houssiau

Annals of the Rheumatic Diseases Aug 2019, annrheumdis-2019-216160; DOI: 10.1136/annrheumdis-2019-216160

Main menu

Systemic Lupus Erythematosus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic Lupus Erythematosus

Pages